| Financial Year |
March 31 2023 |
| Monetary Funds |
12,628,606.41 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,413,212,332.63 |
| Advances to Suppliers |
236,927,605.92 |
| Other Receivables |
39,856,126.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,590,247.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
50,164,668.29 |
| Total Current Assets |
1,843,486,887.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
876,508,266.50 |
| Under-construction Projects |
174,046,899.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
2,067,478.55 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,147,181.84 |
| R&D expenses |
-- |
| Goodwill |
675,429,707.61 |
| Long-Term Deferred and Prepaid Expenses |
270,862.69 |
| Deferred Income Tax Assets |
40,676,878.97 |
| Other Non-Current Assets |
1,693,418.40 |
| Sub-Total of Non-Current Assets |
1,824,822,231.11 |
| Total Assets |
3,668,309,118.72 |
| Short-Term Loans |
527,573,733.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,618,435.52 |
| Accounts Payable |
242,399,599.66 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,282,511.08 |
| Taxes Payable |
132,782,295.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
650,125,437.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
40,490,794.78 |
| Other Current Liabilities |
1,944,468.32 |
| Sub-Total of Current Liabilities |
1,644,024,045.15 |
| Long-term Loans |
342,794,750.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
140,950.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,025,293.00 |
| Deferred Income Tax Liabilities |
6,896,952.10 |
| Other Non-Current Liabilities |
88,107.84 |
| Sub-Total of Non-Current Liabilities |
390,477,474.99 |
| Total Liabilities |
2,034,501,520.14 |
| Paid-In Capital(Or Share Stock) |
350,336,112.00 |
| Capital Surplus |
788,070,563.65 |
| Surplus Reserve |
18,358,424.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-379,050,515.62 |
| Minority Stockholder's Interest |
856,093,014.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
777,714,584.27 |
| Owner's Equity（Stockholder's Equity） |
1,633,807,598.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,668,309,118.72 |
